Carolyn Hamby Shelton - 12 Mar 2025 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Mar 2025, 16:52:26 UTC
Prior SEC filing
10 Feb 2025
Next SEC filing
12 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Carolyn Shelton, Name: Carolyn Shelton

Key filing fact

Carolyn Hamby Shelton filed Form 4 for Nexalin Technology, Inc. (NXL) on 13 Mar 2025.

Key facts

  • This page summarizes Carolyn Hamby Shelton's Form 4 filing for Nexalin Technology, Inc. (NXL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Mar 2025, 16:52.

Change

  • Previous filing in this sequence was filed on 10 Feb 2025.
  • Current net transaction value: +$13,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NXL transaction

Common Stock

Purchase

Transaction value
$13,200
Shares
+6,000
Change %
+25%
Price
$2.20
Shares after
30,000
Date
12 Mar 2025
Ownership
By Husband
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 24,000 shares owned directly by Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .